Gut microbiota dysbiosis testing
The GA-map® Dysbiosis Test measures and monitors gut microbiota status in patients with irritable bowel syndrome.
Source: LinkedIn company description · Retrieved October 13, 2026
Genetic Analysis AS focuses on molecular in-vitro diagnostics of diseases related to gut imbalances.
Its DNA-based GA-map® platform generates patient gut microbiota profiles that can be related to various health conditions. The company identifies potential test applications in diagnosis, disease severity course, treatment prediction and monitoring for IBS and IBD, where clinical data and validation are required.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The GA-map® Dysbiosis Test helps gastroenterologists measure and monitor gut microbiota status in patients with irritable bowel syndrome.
The GA-map® Dysbiosis Test measures and monitors gut microbiota status in patients with irritable bowel syndrome.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.